China Biologic Products, Inc. (CBPO:NASDAQ) Investor Relations Material

Overview

China Biologic Products, Inc. (NASDAQ: CBPO) is a prominent Chinese biopharmaceutical company that specializes in plasma-based therapies. The company's products are widely used for emergency medical situations and to prevent and treat life-threatening illnesses related to immune deficiencies. With its headquarters in Beijing, China Biologic produces more than 20 different dosage forms of plasma products through its majority owned subsidiary, Shandong Taibang Biological Products Co., Ltd., and wholly owned subsidiary, Guizhou Taibang Biological Products Co., Ltd.

Annual Reports

Frequently Asked Questions

What is China Biologic Products, Inc.'s ticker?

China Biologic Products, Inc.'s ticker is CBPO

What exchange is China Biologic Products, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are China Biologic Products, Inc.'s headquarters?

They are based in Beijing, China

How many employees does China Biologic Products, Inc. have?

There are 1001-5000 employees working at China Biologic Products, Inc.

What is China Biologic Products, Inc.'s website?

It is http://www.chinabiologic.com/

What type of sector is China Biologic Products, Inc.?

China Biologic Products, Inc. is in the Healthcare sector

What type of industry is China Biologic Products, Inc.?

China Biologic Products, Inc. is in the Biotechnology industry

Who are China Biologic Products, Inc.'s peers and competitors?

The following five companies are China Biologic Products, Inc.'s industry peers:

- Intercept Pharmaceuticals

- Aurinia Pharmaceuticals Inc.

- Exact Sciences

- Ocugen

- Merrimack Pharmaceuticals Inc